Arcadia Biosciences, Inc.
RKDA· Nasdaq
Released Mar 30, 2021, after the close
10-K filed Mar 31, 2021, 90 days after period end · 0001564590-21-017118
derived · Computed from the longer spans the company filed.
| Metric | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures |
|---|---|---|---|---|
| Revenue | $7.13M | $416.00K | $444.00K | $1.43M |
| Net Income | $8.90M |
Arcadia Biosciences, Inc. · CIK 1469443 · Engraved from SEC EDGAR
| -$6.24M |
| -$646.00K |
| -$2.96M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.